Radiopharmaceutical therapy for metastatic prostate cancer: Insights from mechanistic modeling and in silico trials
Matteo Italia, Silvia Bordel-Vozmediano, José García Otero, Gabriel F. Calvo, Víctor M. Pérez‐García
This paper develops a mechanistic model to simulate [177Lu]Lu-PSMA RPT in mCRPC, using virtual patients to optimize dosing schedules and evaluate efficacy-toxicity trade-offs.
bioRxiv · Dec 19, 2025 · PreprintCancer Biology